Clinical Trials
All Clinical Trials - Page 42 of 74
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT02906150Phase 2Unknown
Thymosin Alpha 1 Plus Maintenance Therapy With the Standard of Care (SoC) in Patients With Metastatic Non-Small Cell Lung Cancer (NSCLC), EGFR Wild Type
Thymosin-Alpha-1
- NCT02862782Phase 3Unknown
Combination of Gonadotropin-releasing Hormone Agonist and Human Chorionic Gonadotropin Triggered by Normal Responder in GnRH-antagonist Cycles
Gonadorelin
- NCT02908438Phase 1Unknown
Gonadotrophin Releasing Hormone Agonist Addition for Luteal Support in In-vitro Fertilization and Embryo Transfer Cycles
Gonadorelin
- NCT02935023Phase 2Unknown
Carbon Ion Radiotherapy in Treating Patients Undergoing Systemic Therapy for Oligo-metastatic Prostate Cancer
Gonadorelin
- NCT04122716Phase 4Unknown
Combined Effects of GLP-1 Analogue and Exercise on Maintenance of Weight Loss and Health After Very-low Calorie Diet
Liraglutide
- NCT02911818Phase 4Completed
Lifestyle Modification and Liraglutide
Liraglutide
- NCT02930265N/AUnknown
Clinical Study of Liraglutide in Improving Cardiac Function for Patients With Ischemic Cardiomyopathy
Liraglutide
- NCT02743598Phase 4Terminated
Liraglutide for HIV-associated Neurocognitive Disorder
Liraglutide
- NCT02916433Phase 2Completed
Octreotide for Management of Bronchorrhea in Mechanically Ventilated Patients
Octreotide
- NCT02904759Phase 3Completed
Trial of Desmopressin Orally Disintegrating Tablets (ODT) for Nocturia Due to Nocturnal Polyuria in Japanese Male Subjects
Desmopressin
- NCT02905682Phase 3Completed
Trial of Desmopressin Orally Disintegrating Tablets (ODT) for Nocturia Due to Nocturnal Polyuria in Japanese Female Subjects
Desmopressin
- NCT02877355Phase 1Completed
Investigation of the Effect of Upper Gastrointestinal Disease on the Pharmacokinetics of Oral Semaglutide in Subjects With Type 2 Diabetes.
Semaglutide
- NCT02805790Phase 2Completed
Safety, Tolerability, Efficacy of MTP-131 for Treatment of Mitochondrial Disease in Subjects From the MMPOWER Study
Elamipretide
- NCT02870231Phase 1Completed
Investigating Safety, Tolerability, PK and PD for Multiple Doses of NNC9204-0530 in Combination With Liraglutide in Male and Female Subjects Being Overweight or With Obesity
Liraglutide
- NCT02843399N/ACompleted
Economic Outcomes of EQW (Exenatide Once Weekly) vs. IG (Insulin Glargine) in T2D Patients Who Are New to Injectable Therapy
Exenatide
- NCT02741154Phase 4Completed
Role of Aromatase Inhibitor to Enhance Ovulation in Poor Responder During Induction With Short Antagonist Protocol in Cases of ICSI
Gonadorelin
- NCT02863419Phase 3Completed
Efficacy and Safety of Oral Semaglutide Versus Liraglutide and Versus Placebo in Subjects With Type 2 Diabetes Mellitus
Semaglutide
- NCT02863328Phase 3Completed
Efficacy and Safety of Oral Semaglutide Versus Empagliflozin in Subjects With Type 2 Diabetes Mellitus
Semaglutide
- NCT05945407N/ARecruiting
Fertility-sparing Therapy for Patients With Stage IA Endometrial Cancer
Gonadorelin
- NCT04325581Phase 3Completed
Laparocopic Sleeve Gastrectomy With or Without Liraglutide in Obese Patients
Liraglutide
- NCT02734641N/ACompleted
Does Increase in Appetite After Iron Treatment Induced by Ghrelin Hormone
Ghrp-6
- NCT02827656N/AUnknown
Comapring Luteal Phase Support in IVF Patients Who Are at High Risk for Developing OHSS
Gonadorelin
- NCT02895672N/ACompleted
GLP-1/Basal Insulin Combination Therapy
Liraglutide
- NCT02846233N/ACompleted
Stepping-down Approach in Patients With Chronic Poorly-controlled Diabetes on Advanced Insulin Therapy?
Dulaglutide
- NCT02750410Phase 4Completed
A Study of Dulaglutide in Japanese Participants With Type 2 Diabetes
Dulaglutide
- NCT02838589Phase 2Completed
The Effect of GLP-1 Receptor Agonist on Cerebral Blood Flow Velocity in Non-stroke Volunteers
Exenatide
- NCT03002675Phase 4Unknown
Exenatide and Brown Adipose Tissue
Exenatide
- NCT02829502Phase 2Unknown
The Effect of GLP-1 Receptor Agonist on Cerebral Blood Flow Velocity in Stroke
Exenatide
- NCT02767596Phase 4Terminated
Evaluation of Lixisenatide Efficacy in Diabetes Mellitus Type 2 With Failure of Other GLP-1 Analog
Lixisenatide
- NCT02787551Phase 3Completed
Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (FRC) Versus GLP-1 Receptor Agonist in Patients With Type 2 Diabetes, With a FRC Extension Period
Liraglutide
- NCT03791736N/ATerminated
Evaluation of Impact of Sandostatin® Injection Before Axillary Clearance on Lymphocele Formation
Octreotide
- NCT03236545N/ACompleted
Menopause Effects on Vascular Function
Gonadorelin
- NCT02758431N/ACompleted
Cardiovascular Outcomes of Low Testosterone
Gonadorelin
- NCT02865681N/ACompleted
Protocol to Minimize Injections and Blood Draws for Women Undergoing in Vitro Fertilization
Gonadorelin
- NCT03734627N/ACompleted
Gastrointestinal Nutrient Transit and Enteroendocrine Function After Upper Gastrointestinal Surgery
Octreotide
- NCT02806414Phase 1/Phase 2Completed
Evaluation of the Inhibitory Effects of Topical Ivermectin on Markers of Rosacea Specific Inflammation.
Ll-37
- NCT02783196N/AUnknown
Effect of Liraglutide on Clock Genes
Liraglutide
- NCT02975297Phase 1/Phase 2Completed
Exenatide Once Weekly for Smoking Cessation
Exenatide
- NCT01587222Phase 2Withdrawn
Midodrine, Octreotide and Albumin: Impact on Renal Function of Patients With Liver Cirrhosis and Renal Failure
Octreotide
- NCT02691078Phase 2Completed
Validation of 99mTc- EDDA - HYNIC -TOC Kits for Diagnosis of Neuroendocrine Tumors
Octreotide
- NCT02698410Phase 2Completed
Efficacy and Safety of Lanreotide Autogel (ATG) in Combination With Temozolomide in Subjects With Thoracic Neuroendocrine Tumors.
Lanreotide
- NCT02807233N/ACompleted
Lanreotide Autogel 120 mg at Extended Dosing Intervals (>4 Weeks) in Acromegalic Subjects
Lanreotide
- NCT02809105Phase 3Completed
A Study of Oral Dosing of ASP0456 in Patients With Chronic Constipation
Linaclotide
- NCT02682381Phase 3Completed
Short Bowel Syndrome Research Study for Children Up To 17 Years of Age on Parenteral Nutrition
Teduglutide
- NCT02795858Phase 2Completed
A Phase II Study of Ramucirumab With Somatostatin Analog Therapy in Patients With Advanced, Progressive Carcinoid Tumors
Octreotide
- NCT05762744Phase 1Terminated
Pharmacogenomics of GLP1 Receptor Agonists
Exenatide
- NCT04857801N/ACompleted
Teduglutide in Short Bowel Syndrome Patients
Teduglutide
- NCT03017768N/ACompleted
The Effect of Acute Tryptophan Depletion (ATD) on Esophageal Sensitivity in Healthy Volunteers
KPV
- NCT02736591Phase 3Unknown
Dehydroepiandrosterone Versus Growth Hormone in Women Undergoing ICSI With Expected Poor Ovarian Response
Sermorelin
- NCT02788747Phase 2Completed
Effect of Elamipretide on Left Ventricular Function in Subjects With Stable Heart Failure With Reduced Ejection Fraction
Elamipretide